News
How old is too old to be on a kids’ protocol for ALL?
Photo by Bill Branson SAN DIEGO—In recent years, pediatric or pediatric-inspired protocols have become the preferred treatment approach for...
News
Another treatment on the horizon for SCD
Photo courtesy of ASH SAN DIEGO—The first-in-class humanized anti-P-selectin antibody SelG1, also known as crizanlizumab, significantly reduced...
News
Potential treatment for cGVHD after steroid failure
2016 ASH Annual Meeting SAN DIEGO—Ibrutinib, a Bruton’s tyrosine kinase inhibitor approved to treat chronic lymphocytic leukemia and other...
News
Pacritinib bests BAT despite study truncation
SAN DIEGO—The JAK2/FLT3 inhibitor pacritinib significantly reduces spleen volume and symptoms in patients with myelofibrosis and low platelet...
News
Gene transfer for hemophilia B shows progress
SAN DIEGO—Researchers say they have optimized the SPK-9001 adeno-associated viral (AAV) vector so that a “simple infusion” has significantly...
News
Herbal medicine can reduce pain, fatigue in SCD patients
Convention Center, site of the 2016 ASH Annual Meeting SAN DIEGO—Results of a phase 1 study suggest that SCD-101, a botanical extract based on an...
News
Combine flow and HTS for sensitive MRD detection in CLL, speaker says
NEW YORK—Combining 2 technologies—flow cytometry and high-throughput sequencing (HTS)—produces a very sensitive approach to detecting minimal...
News
Rethinking testing in multiple myeloma
NEW YORK—As the number of therapeutic options for multiple myeloma (MM) increases, so too does the need to reassess prognostic markers for the...
News
Genetic screening for CLL premature, speaker says
Photo courtesy of the National Institute of General Medical Science NEW YORK—Research has shown that family history is a strong risk factor for...
News
No longer a hand-me-down approach to WM
NEW YORK—Whole-genome sequencing has changed the entire approach to drug development for Waldenström’s macroglobulinemia (WM), according to a...
News
Speaker says use the best regimen ASAP in MM
NEW YORK—It’s important to use the best possible regimen as soon as possible when treating patients with multiple myeloma (MM), according to a...
News
Doc provides perspective on CAR T-cell therapy in CLL
Photo from Penn Medicine NEW YORK—Trial data on the use of chimeric antigen receptor (CAR) T cells in chronic lymphocytic leukemia (CLL) are...
News
MF assessment and treatment an ‘evolution’ from the past
NEW YORK—The 11th NCCN Congress: Hematologic Malignancies coincided with the release of the inaugural edition of the NCCN treatment guideline on...
News
Supportive care isn’t palliative care, speaker says
NEW YORK—Two presentations at the NCCN 11th Annual Congress: Hematologic Malignancies addressed the importance of supportive care in the...
News
Speaker outlines importance of cell of origin in DLBCL
NEW YORK—The importance of cell of origin in choosing a treatment for diffuse large B-cell lymphoma (DLBCL) is a topic “that has been kicking...